Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 16/20 | 0.84 |
| ▸ | CDK1 | P06493 | 8/20 | 0.84 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.64 |
| ▸ | CSF1R | P07333 | 1/20 | 0.55 |
| ▸ | CDK4 | P11802 | 1/20 | 0.55 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1447545 | 0.95 | CDK2 (0.82) | CDK2CDK1KCNH2CSF1RCDK4 | |
| SCHEMBL1447350 | 0.95 | CDK2 (0.82) | CDK2CDK1KCNH2CSF1RCDK4 | |
| SCHEMBL1447395 | 0.92 | CDK2 (1.00) | CDK2CDK1KCNH2 | |
| SCHEMBL1447982 | 0.92 | CDK2 (1.00) | CDK2CDK1KCNH2 | |
| SCHEMBL1447239 | 0.85 | CDK2 (0.82) | CDK2CDK1KCNH2 | |
| SCHEMBL1448607 | 0.84 | CDK2 (0.70) | CDK2CDK1KCNH2CSF1RCDK4 | |
| SCHEMBL1448381 | 0.84 | CDK2 (0.69) | CDK2CDK1KCNH2CDK4 | |
| SCHEMBL1447223 | 0.82 | CDK2 (0.83) | CDK2CDK1KCNH2 | |
| SCHEMBL1447542 | 0.82 | CDK2 (0.83) | CDK2CDK1KCNH2 | |
| SCHEMBL1447591 | 0.82 | CDK2 (0.84) | CDK2CDK1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2301928-A1 | Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders | AstraZeneca AB (SE) | 2011-03-30 | — | — | EP | disclosed |